Doximity, Inc.
- Stock
- Ticker DOCS
- NYSE
Performance, volatility and drawdowns of Doximity, Inc. since 06/2021, with distributions reinvested and calculated in US dollars. As of 20 Nov 2026.
Performance
$10,000 grew to $4,135. Global equities (VT): $14,653.
Distributions reinvested, before taxes and brokerage costs. Dashed: Global equities (VT) for comparison.
Declines from the peak
Lowest point −82.3% in 05/2026, measured from the peak in 09/2021. The old peak has not been reached again yet.
Financial statements
Amounts in $ millions from filings with the SEC, earnings per share in $; fourth quarter and quarterly cash flow derived from year-to-date figures
| Quarter end | 12/2024 | 03/2025 | 06/2025 | 09/2025 | 12/2025 | 03/2026 | 06/2026 | 09/2026 |
|---|---|---|---|---|---|---|---|---|
| Income statement | ||||||||
| Revenue | 169 | 138 | 146 | 169 | 185 | 145 | 157 | 175 |
| Gross profit | 154 | 124 | 130 | 152 | 166 | 126 | 133 | 149 |
| Operating income | 80 | 49 | 55 | 64 | 72 | 25 | 34 | 44 |
| EBITDA | 81 | 52 | 57 | 66 | 74 | 29 | 38 | 48 |
| Net income | 75 | 62 | 53 | 62 | 62 | 19 | 24 | 35 |
| Earnings per share | 0.37 | 0.31 | 0.27 | 0.31 | 0.31 | 0.10 | 0.13 | 0.18 |
| Balance sheet | ||||||||
| Total assets | 1,172 | 1,264 | 1,204 | 1,257 | 1,157 | 1,124 | 1,084 | 1,092 |
| Liabilities | 141 | 182 | 179 | 162 | 178 | 173 | 168 | 163 |
| Equity | 1,031 | 1,083 | 1,026 | 1,096 | 979 | 951 | 916 | 928 |
| Cash | 165 | 210 | 137 | 169 | 65 | 219 | 274 | 219 |
| Cash flow | ||||||||
| Operating cash flow | 65 | 98 | 62 | 94 | 61 | 110 | 42 | 93 |
| Capital expenditure | 0.0 | 0.0 | 0.0 | 0.0 | – | – | -0.1 | 0.0 |
| Free cash flow | 65 | 98 | 62 | 94 | 61 | 110 | 42 | 93 |
Value it:DCF calculatorMultiples calculator
Annual returns
Best year 2024 at +90.4%, weakest 2022 at −33.1%. 1 of 4 full years were positive. * partial year.
Quarterly reports
Filing date with the SEC and earnings per share of the quarter
| Day | Earnings per share |
|---|---|
| 5 Nov 2026 | $0.18 |
| 6 Aug 2026 | $0.13 |
| 19 May 2026 | $0.10 |
| 5 Feb 2026 | $0.31 |
| 6 Nov 2025 | $0.31 |
| 7 Aug 2025 | $0.27 |
| 20 May 2025 | $0.31 |
| 6 Feb 2025 | $0.37 |
| 7 Nov 2024 | $0.22 |
| 8 Aug 2024 | $0.21 |
| 23 May 2024 | $0.20 |
| 8 Feb 2024 | $0.24 |
Key metrics
Metrics of 15 Nov 2026; P/E, P/B, P/S, market cap and dividend yield at the last close.
Valuation
- Market cap
- €4.6bn
- Market cap in trading currency
- $5.12bn
- Enterprise value
- $4.90bn
- P/E
- 39.9
- P/S
- 7.74
- P/B
- 5.52
- EV/Sales
- 7.41
- EV/EBITDA
- 25.9
- Earnings yield
- 2.5%
- FCF yield
- 6.0%
Results (last four quarters)
- Revenue
- $662m
- Gross profit
- $574m
- EBITDA
- $189m
- Net income
- $140m
- Earnings per share
- $0.72
- Revenue per share
- $3.71
- Revenue growth
- +3.6%
- Earnings growth
- −44.0%
Profitability
- Gross margin
- 86.8%
- Operating margin
- 26.3%
- Net margin
- 21.1%
- Return on equity
- 13.8%
- Return on assets
- 12.8%
Balance sheet and cash flow
- Cash
- $219m
- Cash per share
- $1.23
- Financial debt
- –
- Debt/equity %
- –
- Current ratio
- 6.37
- Book value per share
- $5.21
- Operating cash flow
- $306m
- Free cash flow
- $306m
Dividend
- Dividend yield
- 0.00%
- Dividend (12 months)
- $0.00
- Yield (12 months)
- 0.00%
- Payout ratio
- 0%
- Ex-dividend date
- –
Shares and trading
- Shares outstanding
- 178m
- Volume
- 2.34m
- Avg. volume 3 months
- 2.81m
- Relative volume
- 0.9
Price and technicals
- Price
- $28.73
- 1 day
- −3.0%
- 52-week high
- $51.53
- 52-week low
- $18.01
- Distance to 52-week high
- −44.2%
- Distance to 52-week low
- +59.5%
- Distance to 50-day line
- −5.1%
- Distance to 200-day line
- +14.6%
- RSI (14)
- 35
- Volatility 1M
- 41.1%
Performance
- 1 week
- −13.8%
- 1 month
- −14.7%
- 3 months
- +13.6%
- 6 months
- +44.1%
- YTD
- −35.1%
- 1 year
- −40.1%
Dates
- Fiscal year end
- 31 Mar 2026
- Most recent quarter
- 30 Sep 2026
Frequently asked questions
How has DOCS performed since 06/2021?
$10,000 grew to $5,421 by 20 Nov 2026, which is −10.7% per year. Distributions are reinvested; taxes and brokerage costs are not deducted.
How volatile is DOCS?
Volatility was 57.6% per year, measured on monthly returns. The largest decline from a peak was −82.3%, with the low in 05/2026.
How does DOCS compare with a broad equity ETF?
Over the same period Global equities (VT) returned +8.1% per year at 15.1% volatility, DOCS returned −10.7% at 57.6%. The correlation of monthly returns was 0.36; 1 would mean they moved in lockstep.
Which currency are the figures in?
In US dollars, the currency of the US listing.